Online Ordering
Featured Articles
LI-COR Introduces Cancer Resource Web Site
July 13, 2010: This new website provides examples of applications and techniques where infrared fluorescence detection contributes to the understanding of cancer and the search for cures.
[Read More]
LI-COR Translational Research Group
The LI-COR Translational Research Group seeks to facilitate the use of IRDye® 800CW imaging agents in clinical studies for detection of disease and its progression, and for monitoring of treatment and drug efficacy.
[Read More]
LI-COR Unveils FieldBrite™ XT Technology
in New Multi-Modality Imager
July 1, 2010, Lincoln, NE: LI-COR Biosciences is now shipping its Odyssey® Fc Imaging System that combines dual-channel infrared fluorescent and chemiluminescent imaging in one system...
[Read More]
8-11
World Molecular Imaging Congress
Booth #316 & 318
September 8-11, 2010
21-24
MipTec 2010
Booth Number #G32
September 21-24, 2010
5-7
BIOTECHNICA
Hall 9, Booth #B12
October 5-7, 2010
18-20
Signal Transduction: Receptors, Mediators and Genes
October 18-30, 2010
14-17
Neuroscience 2010
Booth #701
November 14-17, 2010
1-3
LASA
December 1-3, 2010
7-10
NCRI Cancer Conference
Booth #60
December 7-10, 2010
For More Meetings Click Here
The LI-COR Sentinel:
A Newsletter for Users of LI-COR Technology
Cancer Research Webinar Series
LI-COR Biosciences’ 2010 Cancer Research Webinar Series focuses on the benefits of near-infrared (NIR) fluorescent imaging applications for cancer research. We will discuss quantitative protein analysis and in vivo molecular imaging, and how these methods are used to study analyze common “hallmarks” of cancer.
The third webinar in the Cancer Series is set for 8:30 AM CDT and 1:30 PM CDT on September 23. Registration will open in early September.
View Webinars & Videos by Category:
Lab Spotlight
We value the researchers that use our solutions to achieve advancements in their fields and achieve their own “firsts.”
Read about some of the researchers that have partnered with us, and discover the successes they have achieved as a result.
[Learn More]
Recent Spotlights:
